Literature DB >> 12967811

Conjunctival ulceration following triamcinolone injection.

Shishir Agrawal1, Jaya Agrawal, Trilok Prakash Agrawal.   

Abstract

PURPOSE: To report conjunctival ulceration as a complication of periocular triamcinolone acetonide injection. Interventional case series.
METHODS: Conjunctival ulceration was found in three patients who had anterior subtenon's or subconjunctival deposition of triamcinolone. Cultures from the ulcer edges were negative.
RESULTS: Most of the triamcinolone extruded, and the conjunctival ulcers healed with minimal scarring.
CONCLUSIONS: Conjunctival ulceration was a potential complication of periocular triamcinolone injection in three patients who had anterior subtenon's or subconjunctival deposition of the corticosteroid.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12967811     DOI: 10.1016/s0002-9394(03)00320-9

Source DB:  PubMed          Journal:  Am J Ophthalmol        ISSN: 0002-9394            Impact factor:   5.258


  11 in total

Review 1.  [Ocular side effects and complications of intravitreal triamcinolone acetonide injection].

Authors:  G B Jaissle; P Szurman; K U Bartz-Schmidt
Journal:  Ophthalmologe       Date:  2004-02       Impact factor: 1.059

Review 2.  Pharmacological treatments for thyroid eye disease.

Authors:  Sara P Modjtahedi; Bobeck S Modjtahedi; Ahmad M Mansury; Dinesh Selva; Raymond S Douglas; Robert A Goldberg; Igal Leibovitch
Journal:  Drugs       Date:  2006       Impact factor: 9.546

3.  Orbital steroid injections.

Authors:  R A Goldberg
Journal:  Br J Ophthalmol       Date:  2004-11       Impact factor: 4.638

4.  Intravitreal bevacizumab (Avastin) in combination with verteporfin photodynamic therapy for choroidal neovascularization associated with age-related macular degeneration (IBeVe Study).

Authors:  Rogério A Costa; Rodrigo Jorge; Daniela Calucci; Luiz A S Melo; José A Cardillo; Ingrid U Scott
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2007-02-28       Impact factor: 3.117

5.  Comparison of the efficacy between an intravitreal and a posterior subtenon injection of triamcinolone acetonide for the treatment of diffuse diabetic macular edema.

Authors:  Rao Muhammad Rashad Qamar; Muhammad Imran Saleem; Muhammad Farhan Saleem
Journal:  Eurasian J Med       Date:  2013-10

6.  Changes in the morphology of the hyperemic blebs in eyes undergone trabeculectomy with mitomycin C after injection of triamcinolone acetonide during one-year follow-up.

Authors:  Zakieh Vahedian; Ghasem Fakhraie; Marzye Faraji; Seyed Mehdi Tabatabaei
Journal:  Int Ophthalmol       Date:  2021-06-25       Impact factor: 2.031

Review 7.  Clinical trials on corticosteroids for diabetic macular edema.

Authors:  Hassan A Al Dhibi; J Fernando Arevalo
Journal:  World J Diabetes       Date:  2013-12-15

8.  Conjunctival necrosis following a subconjunctival injection of triamcinolone acetonide in a child.

Authors:  Chong Ying-Jiun; Wong Chee-Kuen; Ismail Shatriah
Journal:  Middle East Afr J Ophthalmol       Date:  2015 Jan-Mar

9.  Intravitreal vs. subtenon triamcinolone acetonide for the treatment of diabetic cystoid macular edema.

Authors:  Mauro Cellini; Alberto Pazzaglia; Eugenio Zamparini; Pietro Leonetti; Emilio C Campos
Journal:  BMC Ophthalmol       Date:  2008-03-17       Impact factor: 2.209

10.  Comparison of the effects of intravitreal bevacizumab and triamcinolone acetonide in the treatment of macular edema secondary to central retinal vein occlusion.

Authors:  Mehmet Demir; Burcu Dirim; Zeynep Acar; Yekta Sendul; Ersin Oba
Journal:  Indian J Ophthalmol       Date:  2014-03       Impact factor: 1.848

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.